Nebenwirkungen · Targretin
Targretin 75 mg soft capsules · Abschnitt 4.8 · PDF-Seite 7
HOS-091542 · Präparat HOS-084349
Table 2 Adverse reactions reported in patients in clinical trials System Organ Class Very Common Common Uncommon (MedDRA terminology*) Blood Dyscrasia Purpura Coagulation Disorder Blood and Coagulation Time Increased2,3 Lymphoma Like Reaction lymphatic Anaemia1 Leucopenia Lymphadenopathy system Thrombocytopenia3 Hypochromic Anaemia1,2,3 disorders Thrombocythemia Eosinophilia1 Leukocytosis2 Lymphocytosis Endocrine Hypothyroidism Thyroid Disorder Hyperthyroidism disorders Weight Gain Gout SGOT Increased Metabolism Bilirubinemia1,3 Hyperlipaemia SGPT Increased and nutrition BUN Increased1 Hypercholesterolaemia Lactic Dehydrogenase Increased disorders High Density Lipoprotein Creatinine Increased Decreased Hypoproteinaemia Ataxia Neuropathy Dizziness Nervous system Vertigo Hypesthesia disorders Hyperaesthesia Insomnia Depression1,2,3 Agitation Cataract Specified1,2,3 Amblyopia3 Visual Field Defect Dry Eyes Eye disorders Corneal Lesion Eye Disorder Abnormal Vision1,2,3 Blepharitis Conjunctivitis3
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-08-12T12:14:00Z · SHA-256 3bf4d2f2fd7cbd6812f185953fbdb6223f58862715009080d9c1b2058c9f08b5 · Passage 66d9bc705c4a571f5fffdd8e86742d46d717195518aed1df52ad77f8cc85afbb · Zeichen 1099–5128 im Abschnitt